Caballero, Jelen S.
HRN: 04-43-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2026
METRONIDAZOLE 500MG (TAB)
04/21/2026
04/27/2026
PO
500 Mg
TID
Thickly MSAF
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: